https://www.prnewswire.com/news-releases/nextbiomedical-announces-first-patient-enrolled-in-us-fda-pivotal-trial-of-nexsphere-f-for-knee-osteoarthritis-pain-302581586.html
251013 피어f 임상 첫 환자 등록완료
251013 피어f 임상 첫 환자 등록완료
PR Newswire
NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain
/PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, today announced the enrollment of the...